Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: Challenges for infection prevention

Infection Control and Hospital Epidemiology

Volumn 35, Issue 4, 2014, Pages 412-418

  Popoola, Victor O ^a   Budd, Alicia ^b   Wittig, Sara M ^b   Ross, Tracy ^a   Aucott, Susan W ^a   Perl, Trish M ^a   Carroll, Karen C ^a   Milstone, Aaron M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; COHORT ANALYSIS; DISEASE SURVEILLANCE; FEMALE; HAND WASHING; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEWBORN; NEWBORN INTENSIVE CARE; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; CROSS INFECTION; EPIDEMIC; ISOLATION AND PURIFICATION; MEDICAL AUDIT; STAPHYLOCOCCAL INFECTIONS; TRANSMISSION; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; BALTIMORE; CROSS INFECTION; DISEASE OUTBREAKS; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MEDICAL AUDIT; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS;

EID: 84895830730     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/675594     Document Type: Article

References (31)

1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122(2):160-166.
2. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birthweight infants with neonatal infection. JAMA 2004;292(19): 2357-2365.
3. Schlapbach LJ, Aebischer M, Adams M, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss National Cohort of extremely premature infants. Pediatrics 2011;128(2):e348-e357.
4. Hocevar SN, Edwards JR, Horan TC, Morrell GC, Iwamoto M, Lessa FC. Device-associated infections among neonatal intensive care unit patients: incidence and associated pathogens reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2012;33(12):1200-1206.
5. Lessa FC, Edwards JR, Fridkin SK, Tenover FC, Horan TC, Gorwitz RJ. Trends in incidence of late-onset methicillin-resistant Staphylococcus aureus infection in neonatal intensive care units: data from the National Nosocomial Infections Surveillance System, 1995-2004. Pediatr Infect Dis J 2009;28(7):577-581.
6. Gerber SI, Jones RC, Scott MV, et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006;27(2):139-145.
7. Milstone AM, Budd A, Shepard JW, et al. Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study. Infect Control Hosp Epidemiol 2010;31(5):558-560.
8. Centers for Disease Control and Prevention (CDC). NHSN patient safety component: CDC/NHSN surveillance definitions for specific types of infections. Atlanta: CDC, 2011.
9. Milstone AM, Carroll KC, Ross T, Shangraw KA, Perl TM. Community-associated methicillin-resistant Staphylococcus aureus strains in pediatric intensive care unit. Emerg Infect Dis 2010; 16(4):647-655.
10. Popoola VO, Carroll KC, Ross T, Reich NG, Perl TM, Milstone AM. Impact of colonization pressure and strain type on methicillin-resistant Staphylococcus aureus transmission in children. Clin Infect Dis 2013;57(10):1458-1460.
11. McDougal LK, Steward CD, Killgore GE, Chaitram JM, Mc-Allister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003;41(11):5113-5120.
12. Milstone AM, Goldner BW, Ross T, Shepard JW, Carroll KC, Perl TM. Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis 2011;53(9):853-859.
13. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillinresistant Staphylococcus aureus infections in the United States. JAMA 2007;298(15):1763-1771.
14. Carey AJ, Della-Latta P, Huard R, et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010;31(6):613-619.
15. Gregory ML, Eichenwald EC, Puopolo KM. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics 2009;123(5):e790-e796.
16. Huang YC, Lien RI, Su LH, Chou YH, Lin TY. Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units-a 7-year campaign. PLoS One 2011; 6(8):e23001.
17. Saiman L, Cronquist A, Wu F, et al. An outbreak of methicillinresistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003;24(5):317-321.
18. Hall IM, Barrass I, Leach S, Pittet D, Hugonnet S. Transmission dynamics of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. J R Soc Interface 2012;9(75):2639-2652.
19. Morel AS, Wu F, Della-Latta P, Cronquist A, Rubenstein D, Saiman L. Nosocomial transmission of methicillin-resistant Staphylococcus aureus from a mother to her preterm quadruplet infants. Am J Infect Control 2002;30(3):170-173.
20. Al-Tawfiq JA. Father-to-infant transmission of communityacquired methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2006;27(6): 636-637.
21. Mitsuda T, Arai K, Fujita S, Yokota S. Epidemiological analysis of strains of methicillin-resistant Staphylococcus aureus (MRSA) infection in the nursery; prognosis of MRSA carrier infants. J Hosp Infect 1995;31(2):123-134.
22. Jimenez-Truque N, Tedeschi S, Saye EJ, et al. Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 2012;129(5):e1252-e1259.
23. Nubel U, Nachtnebel M, Falkenhorst G, et al. MRSA transmission on a neonatal intensive care unit: epidemiological and genome-based phylogenetic analyses. PLoS One 2013;8(1): e54898.
24. Huang YC, Su LH, Wu TL, Lin TY. Molecular surveillance of clinical methicillin-resistant Staphylococcus aureus isolates in neonatal intensive care units. Infect Control Hosp Epidemiol 2005; 26(2):157-160.
25. Milstone AM, Song X, Coffin S, Elward A. Identification and eradication of methicillin-resistant Staphylococcus aureus colonization in the neonatal intensive care unit: results of a national survey. Infect Control Hosp Epidemiol 2010;31(7):766-768.
26. Delaney HM, Wang E, Melish M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013;33(4):313-318.
27. Hitomi S, Kubota M, Mori N, et al. Control of a methicillinresistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000;46(2):123-129.
28. Huang YC, Chou YH, Su LH, Lien RI, Lin TY. Methicillinresistant Staphylococcus aureus colonization and its association with infection among infants hospitalized in neonatal intensive care units. Pediatrics 2006;118(2):469-474.
29. Maraqa NF, Aigbivbalu L, Masnita-Iusan C, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit. Am J Infect Control 2011;39(1):35-41.
30. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17(12):811-813.
31. Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012;32(1):4-9.